BioCardia Shares Double After FDA Approves CardiAMP Trial
By Dean Seal Shares of BioCardia more than doubled after the company said regulators have approved a Phase 3 trial of its CardiAMP treatment for patients...
Peter Altman Drug Administration Executive Peter Altman Dean Seal Article Normal Medical Equipment Supplies
Source: marketwatch.com